NRAS and mixed phenotype acute leukemia: Furthermore, genomic analysis of 159 pediatric MPAL cases by Alexander et al showed that RAS pathway alterations were seen in 63% of B/My MPAL cases, with NRAS mutations contributing to a large proportion of these alterations.4